Biomeme Inc.
Edit

Biomeme Inc.

http://www.biomeme.com/
Last activity: 20.07.2023
Active
Categories: AppDataDiagnosticsHealthTechInformationITLabManagementMobilePlatform
Biomeme's platform transforms your smartphone into a mobile lab for advanced DNA diagnostics and real-time disease surveillance. The system includes a docking station for real-time qPCR, a mobile app to control the system and analyze results, and targeted test kits for preparing samples and identifying pathogens or diseases by their specific DNA or RNA signatures. The cutting edge platform performs to the gold standard used by the world's most advanced central labs but requires no lab equipment or special experience to use.

The low-cost, user-friendly system enables mobile testing at the point-of-need for health care (mobile clinics, disease tracking, home use), agriculture (plant disease tracking, food safety), vector surveillance (Malaria, West Nile mosquitos), veterinary medicine, environmental monitoring (soil and water safety), and even education and citizen science.
Likes
951
Followers
1.6K
Website visits
29.1K /mo.
Mentions
39
Location: United States, Pennsylvania, Philadelphia
Employees: 51-200
Total raised: $21M
Founded date: 2012

Investors 6

Funding Rounds 1

DateSeriesAmountInvestors
20.12.2021-$21M-

Mentions in press and media 39

DateTitleDescription
20.07.2023Biomeme Collaborates with NIH-funded Antibacterial Resistance Leadership Group to Evaluate Host Response Test, Differentiating Bacterial & Viral Infections to Combat AMRAMR is a systemic and global problem of huge proportions against which progress has been stalled during COVID-19. Creating preventative approaches to promote prudent antimicrobial use through a One Health approach is imperative to addressin...
05.06.2023Prestigious Award for Life Sciences & Healthcare Emerging 2023We are honored to receive this award,” said Max Perelman, CEO at Biomeme. Since our founding in 2012, we've gone from our first prototype PCR thermocycler using a travel hair dryer and an iPhone 4 to being a leading biotechnology companies ...
20.03.2023Biomeme Supports Biosecurity Surveillance Program Launched by Ginkgo Bioworks and the Ukraine Ministry of HealthOur partnership with Concentric by Ginkgo continues to strengthen because of our alignment and focus on Biosecurity. We share in their belief that a “biosecurity in a box” model could be a way to manage biosecurity concerns in crisis zones,...
04.10.2022Biomeme To Launch Portable Sample-To-Answer PCR System, Host-Response TestingIt also precipitated a dramatic expansion for Philadelphia-based mini PCR instrument and assay developer Biomeme. The company is now using revenues from CAP and CLIA accredited testing labs it owns to create a sample-to-answer instrument an...
09.09.2021Biomeme Appoints Ephraim Tsalik, MD, PhD as Chief Medical OfficerEphraim Tsalik, Chief Medical Officer at Biomeme, Inc Our team is focused on developing revolutionary point-of-care technology to better diagnose and manage disease. Together with the Biomeme team, I will leverage my experience to deliver o...
27.08.2021Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in HealthcarePredigen’s acquisition will expand Biomeme’s capabilities across infectious disease and clinical microbiology, business management, and commercialization. redigen’s portfolio includes flagship host gene expression biomarkers for the pre-sym...
26.08.2021Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in HealthcarePredigen and Biomeme Host Response Test System (HR-BV) PHILADELPHIA (PRWEB) August 26, 2021 Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic ...
06.04.2021After a Pandemic Growth Spurt, COVID-19 Test Maker Biomeme is Moving its HQ to North Broad and Looking to the FutureEnter a global pandemic. The company, now about 280 employees across the U.S. and about 120 in the Philadelphia region, has outgrown its office. It will join esports company Nerd Street Gamers at a 44,000-square-foot office, lab, testing an...
05.04.2021After a pandemic growth spurt, COVID-19 test maker Biomeme is moving its HQ to North Broad and looking to the futureAbout this time last year, Biomeme — makers of a rapid COVID-19 test and other diagnostic hardware — had about 35 people in its 10th and Chestnut streets HQ. Enter a global pandemic. The company, now about 280 employees across the U.S. and ...
31.03.2021Biomeme & One Health Labs Announce Partnership with Ginkgo Bioworks to Address National Pandemic with Pooled Testing at K-12 SchoolsStudent self collecting swab sample As communities across America work to accomplish the national priority of returning to in-person learning over the coming months, testing will be a critical tool to monitor viral spread and build confiden...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In